# Hereditary Cancer Donor Screening Xytex Adds Cancer Risk Testing to Donor Qualification By Mursal Rahman | Written with AI assistance | Published 2026-10-07 | Lifestyle Source: Trend Hunter, https://www.trendhunter.com/trends/hereditary-cancer-screening References: [prnewswire](https://www.prnewswire.com/news-releases/xytex-expands-donor-screening-to-include-hereditary-cancer-genetic-testing-302898337.html)  Xytex is expanding hereditary cancer donor screening by incorporating Natera’s Empower test into the qualification process for all new donor candidates. Introduced to the protocol in January 2026 following pilot testing, the assessment identifies certain inherited variants associated with an individual’s predisposition to cancer. It operates separately from Natera’s Horizon reproductive carrier screening, which evaluates variants connected to conditions that could be inherited by a child. Relevant Empower information will appear in qualifying donor profiles for families and care teams to consider. The expanded protocol gives Xytex another layer of genetic information within its donor selection process. Providing these results may help intended parents and healthcare professionals make more informed choices alongside existing health and genetic details. For Xytex, incorporating newer testing capabilities also strengthens its screening services as reproductive medicine and genetic science continue to develop. Image Credit: Xytex ## Trend Insights (Trend Hunter) - Score: 4.1/10 - Popularity: 10% | Activity: 14% | Freshness: 99% - Audience gender: 50% men, 50% women - Primary generations: Millennial, Gen X - Top markets: North America ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Lifestyle](https://www.trendhunter.com/lifestyle) > [Health](https://www.trendhunter.com/health) ## Key Themes ### What's Driving This Trend - **Hereditary Risk Profiling:** Expanded donor evaluations that include inherited cancer predisposition data create space for more transparent, genetics-informed decision-making in reproductive care. - **Precision Donor Qualification:** Advanced screening protocols are reshaping donor selection by combining reproductive carrier insights with broader long-term health risk indicators. - **Genetic Transparency Platforms:** Integrated profile systems that surface clinically relevant genetic findings can differentiate fertility services through richer data access for families and care teams. ### Who This Affects Most - **Reproductive Medicine:** Fertility providers are gaining new avenues to personalize donor matching as genetic science becomes more embedded in patient counseling and care planning. - **Genetic Testing:** Diagnostic companies can expand beyond carrier screening into adjacent risk-assessment markets tied to preventive health and family-building decisions. - **Donor Services:** Sperm and egg banks may compete on the depth and clarity of genetic disclosures as intended parents seek more comprehensive donor information. ## Related on Trend Hunter - [At-Home Cervical Screening](https://www.trendhunter.com/trends/At-home-cervical-screening.md) - [Next-Gen Companion Diagnostic Tests](https://www.trendhunter.com/trends/companion-diagnostic-test.md) - [Seamless Oncology Test Integrations](https://www.trendhunter.com/trends/precision-oncology.md) - [Lab-Grown Fertility Solutions](https://www.trendhunter.com/trends/Lab-grown-fertility-solutions.md) - [IVF-Compatible Genetic Optimization Services](https://www.trendhunter.com/trends/genetic-optimization.md) - [Genetic Insight IVF Partnerships](https://www.trendhunter.com/trends/fertility-institute-of-hawaii.md) - [Screening-to-Procedure Navigation](https://www.trendhunter.com/trends/colorectal-screening-navigation.md) - [First Responders-Focused Cancer Screenings](https://www.trendhunter.com/trends/screen-shield.md) - [AI-Assisted Cancer Screenings](https://www.trendhunter.com/trends/multi-cancer-screening-service.md)